Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Ashley Lauricella

Physician Assistant, Surgical Amherst, NY Physician Assistant

NPI 1447802632 CMS profile 10866025

3925 Sheridan Dr, Amherst, NY 14226

Open in the dashboard

General payments

$5,816

58 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ashley Lauricella of Amherst, NY is reported in the CMS Open Payments database as having received $5,816 across 58 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Physician Assistant, Surgical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,308 20
2024 General $661 11
2023 General $551 11
2022 General $373 5
2021 General $923 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ashley Lauricella
  • Physician Assistant, Surgical median
  • Middle half of Physician Assistant, Surgical
  • National median

In program year 2025, general payments to Ashley Lauricella were reported at $3,308. Among 8,152 Physician Assistant, Surgical profiles paid that year, the median was $146 and the middle half received between $51 and $385.

Show as a table
Year Ashley Lauricella Physician Assistant, Surgical median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $923 $111 $36–$285 $132
2022 $373 $126 $44–$350 $149
2023 $551 $137 $47–$355 $160
2024 $661 $146 $49–$384 $164
2025 $3,308 $146 $51–$385 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Arthrex, Inc. $1,647 14 payments
  2. Prodigy Surgical Distribution, Inc. $1,642 5 payments
  3. Endo Pharmaceuticals Inc. $568 9 payments
  4. Boehringer Ingelheim Pharmaceuticals, Inc. $375 3 payments
  5. Amgen Inc. $299 5 payments
  6. GlaxoSmithKline, LLC. $225 2 payments
  7. Horizon Therapeutics plc $188 5 payments
  8. Endo USA, Inc. $158 2 payments
  9. Biohaven Pharmaceutical Holding Company Ltd. $125 1 payment
  10. Lundbeck LLC $125 1 payment
  11. Other $462 11 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $3,052 51 payments
  2. Travel and Lodging $2,763 7 payments
Products named General payments · program years 2021–2025
  1. XIAFLEX $727 11 payments
  2. TRELEGY ELLIPTA $225 2 payments
  3. KRYSTEXXA Krystexxa $188 5 payments
  4. KRYSTEXXA Inflammation/Rare Disease $174 4 payments
  5. FARXIGA $125 1 payment
  6. NURTEC ODT $125 1 payment
  7. VYEPTI $125 1 payment
  8. VARIAX $99 2 payments
  9. Bioinductive Implant with Arthroscopic Delivery System - Medium $83 2 payments
  10. Avance Nerve Graft $65 1 payment
  11. Other $275 10 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

357

Median for Physician Assistant: 241

Drug cost

$1,577

Median for Physician Assistant: $4,110

Branded share of claims

36.4%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 96 $451
Ibuprofen Generic 31 $319
Methylprednisolone Generic 23 $167
Cephalexin Generic 19 $152
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 17 $139
Meloxicam Generic 31 $126
Tramadol Hcl Generic 78 $101
Acetaminophen-Codeine Acetaminophen With Codeine Brand 17 $52
Amoxicillin Generic 27 $40
Ondansetron Hcl Generic 18 $33

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 29 billing codes

Paid by Medicare

$20,795

Of which drugs: $1,400

Medicare patients

186

Average age 72

Services billed

786

109 women, 77 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 72%
Diabetes 30%
Chronic kidney disease 30%
Depression 26%
Ischemic heart disease 24%
Atrial fibrillation 17%
COPD 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 71 281 $1,400

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XIAFLEX
  • Endo USA, Inc. $158
  • Endo Pharmaceuticals Inc. $100
$259 — —
KRYSTEXXA
  • Amgen Inc. $156
$156 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

58 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Surgical in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record